Cargando…
Natural Compounds as Therapeutic Agents in the Treatment Cystic Fibrosis
The recent FDA approval of two drugs to treat the basic defect in cystic fibrosis has given hope to patients and their families battling this devastating disease. Over many years, with heavy financial investment from Vertex Pharmaceuticals and the Cystic Fibrosis Foundation, pre-clinical evaluation...
Autores principales: | , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4828912/ https://www.ncbi.nlm.nih.gov/pubmed/27081574 http://dx.doi.org/10.4172/2157-7412.1000284 |
_version_ | 1782426675047301120 |
---|---|
author | Dey, Isha Shah, Kalpit Bradbury, Neil A |
author_facet | Dey, Isha Shah, Kalpit Bradbury, Neil A |
author_sort | Dey, Isha |
collection | PubMed |
description | The recent FDA approval of two drugs to treat the basic defect in cystic fibrosis has given hope to patients and their families battling this devastating disease. Over many years, with heavy financial investment from Vertex Pharmaceuticals and the Cystic Fibrosis Foundation, pre-clinical evaluation of thousands of synthetic drugs resulted in the production of Kalydeco and Orkambi. Yet, despite the success of this endeavor, many other compounds have been proposed as therapeutic agents in the treatment of CF. Of note, several of these compounds are naturally occurring, and are present in spices from the grocery store and over the counter preparations in health food stores. In this short review, we look at three such compounds, genistein, curcumin, and resveratrol, and evaluate the scientific support for their use as therapeutic agents in the treatment of patients with CF. |
format | Online Article Text |
id | pubmed-4828912 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2016 |
record_format | MEDLINE/PubMed |
spelling | pubmed-48289122016-04-12 Natural Compounds as Therapeutic Agents in the Treatment Cystic Fibrosis Dey, Isha Shah, Kalpit Bradbury, Neil A J Genet Syndr Gene Ther Article The recent FDA approval of two drugs to treat the basic defect in cystic fibrosis has given hope to patients and their families battling this devastating disease. Over many years, with heavy financial investment from Vertex Pharmaceuticals and the Cystic Fibrosis Foundation, pre-clinical evaluation of thousands of synthetic drugs resulted in the production of Kalydeco and Orkambi. Yet, despite the success of this endeavor, many other compounds have been proposed as therapeutic agents in the treatment of CF. Of note, several of these compounds are naturally occurring, and are present in spices from the grocery store and over the counter preparations in health food stores. In this short review, we look at three such compounds, genistein, curcumin, and resveratrol, and evaluate the scientific support for their use as therapeutic agents in the treatment of patients with CF. 2016-01-30 2016-02 /pmc/articles/PMC4828912/ /pubmed/27081574 http://dx.doi.org/10.4172/2157-7412.1000284 Text en http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. |
spellingShingle | Article Dey, Isha Shah, Kalpit Bradbury, Neil A Natural Compounds as Therapeutic Agents in the Treatment Cystic Fibrosis |
title | Natural Compounds as Therapeutic Agents in the Treatment Cystic Fibrosis |
title_full | Natural Compounds as Therapeutic Agents in the Treatment Cystic Fibrosis |
title_fullStr | Natural Compounds as Therapeutic Agents in the Treatment Cystic Fibrosis |
title_full_unstemmed | Natural Compounds as Therapeutic Agents in the Treatment Cystic Fibrosis |
title_short | Natural Compounds as Therapeutic Agents in the Treatment Cystic Fibrosis |
title_sort | natural compounds as therapeutic agents in the treatment cystic fibrosis |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4828912/ https://www.ncbi.nlm.nih.gov/pubmed/27081574 http://dx.doi.org/10.4172/2157-7412.1000284 |
work_keys_str_mv | AT deyisha naturalcompoundsastherapeuticagentsinthetreatmentcysticfibrosis AT shahkalpit naturalcompoundsastherapeuticagentsinthetreatmentcysticfibrosis AT bradburyneila naturalcompoundsastherapeuticagentsinthetreatmentcysticfibrosis |